Drug
lenacapavir sodium
Marketed as SUNLENCA.
Generic name
lenacapavir sodium
Brand names
SUNLENCA
First FDA approval
2022-12-22
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA215974 | SUNLENCA | 2022-12-22 | GILEAD SCIENCES INC |
| NDA215973 | SUNLENCA | 2022-12-22 | GILEAD SCIENCES INC |
Manufacturers
GILEAD SCIENCES INC
Frequently asked questions
When was lenacapavir sodium FDA approved?
Earliest FDA approval on record: 2022-12-22.
What brand names are sold as lenacapavir sodium?
SUNLENCA.
Sources
Appeal a lenacapavir sodium denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com